FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Skyrizi
since
auto-detected in 1 stories
27 days ago
Johnson & Johnson said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots.
page 1 of 1